Paul Buonaguro, attorney from our Tax & Benefits team, discuss the potential tax pitfalls biotech startups can face when partnering with large pharmaceutical companies, particularly when entering new states. They cover how a collaboration deal can trigger unexpected state income taxes and other Continue Reading
Judge Young on Judging — Reflections from Nearly 50 Years on the Bench
Dean Elwell, a member of the Massachusetts Bar Association’s Complex Commercial Litigation Section Council, authored “Judge Young on Judging — Reflections from Nearly 50 Years on the Bench,” published in the January/February issue of the Massachusetts Bar Association’s Section Review. In the first Continue Reading
Trump Administration Shifts DOJ’s Approach to FCPA Enforcement
On February 10, 2025, President Trump signed an Executive Order (EO) directing Attorney General Pam Bondi to halt ongoing enforcement by the Department of Justice (DOJ) in all active prosecutions brought pursuant to the Foreign Corrupt Practices Act (FCPA). The EO also requires the DOJ to cease Continue Reading
KKR Countersues DOJ for Confusing and Contradictory HSR Rules
Not every investment firm countersues the acting assistant attorney general of the United States for the Antitrust Division, the United States Department of Justice (Antitrust Division), the Federal Trade Commission (FTC), and the United States of America (together, the Defendants) when the Continue Reading
Healthcare Consolidation and Private Equity: Public Input on Antitrust Healthcare Regulations
The Department of Justice Antitrust Division (DOJ), the Federal Trade Commission (FTC), and the Department of Health and Human Services (HHS) (together the Agencies) launched a cross-government agency request for information (RFI) seeking public comments on consolidation in the healthcare industry Continue Reading
DOJ Signals Potential Criminal Enforcement Against Private Sector for Diversity Equity and Inclusion (DEI) and Diversity Equity Inclusion and Accessibility (DEIA) Programs
On February 5, 2025, upon her swearing-in, US Attorney General Pamela Bondi issued multiple policy memoranda identifying various priorities of the Department of Justice (DOJ) under the Trump Administration. Among them is a memorandum entitled: “Ending Illegal DEI And DEIA Discrimination And Continue Reading
Antitrust Guidelines for Worker-Related Business Practices: How to Stay on the Right Side of Antitrust Hiring Laws During the Administration Transition
The Department of Justice Antitrust Division (DOJ) and the Federal Trade Commission (FTC) (together, the Agencies) issued Antitrust Guidelines for Business Activities Affecting Workers (2025 Guidelines) in January. The 2025 Guidelines replace the 2016 Antitrust Guidance for Human Resource Continue Reading
Delaware Court Holds Settlement of Underlying Securities Litigation Is Covered Under D&O Policy, Rejecting Insurers’ Assertion of the ‘Bump-Up’ Exclusion
A Delaware court recently found for the policyholders in determining that a directors and officers (D&O) liability policy covered the settlement of an underlying action alleging violations of the Securities Exchange Act of 1934 (the Exchange Act). Indeed, in Harman International Industries, Inc. Continue Reading
AI and Land Use—a Perfect Match in Real Estate Heaven
The capabilities of AI are boundless, and its effects promise to introduce new dimensions to the present land use planning regimes. Yet, despite these benefits, human expertise, and the human perspective in land use remain indispensable. Feb. 6, 2025 In a world driven by efficiency, artificial Continue Reading
FTC Surveillance Pricing Study Finds Personal Data Is Used to Set Individualized Consumer Prices and Generate Higher Profits for Companies
On January 17, 2025, the US Federal Trade Commission (FTC) released the preliminary observations and findings from its ongoing study of surveillance pricing. According to the FTC, surveillance pricing occurs when companies leverage advanced data collection technologies to adjust the prices of goods Continue Reading